SODIUM NITROPRUSSIDE (nitroprusside sodium)
NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2
Pfizer Laboratories
Drug class
Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway
The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism. Read more about Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway
26 drugs in this class 22 manufacturers
Drugs in Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway
REVATIO (sildenafil citrate)
AGENTS TO TREAT ERECTILE DYSFUNCTION, CGMP-TYPE · PULMONARY ARTERIAL HYPERTENSION
Parke-Davis Pfizer
REVATIO (sildenafil citrate)
AGENTS TO TREAT ERECTILE DYSFUNCTION, CGMP-TYPE · PULMONARY ARTERIAL HYPERTENSION
Parke-Davis Pfizer
REVATIO (sildenafil citrate)
AGENTS TO TREAT ERECTILE DYSFUNCTION, CGMP-TYPE · PULMONARY ARTERIAL HYPERTENSION
Parke-Davis Pfizer
SODIUM NITROPRUSSIDE (nitroprusside sodium)
NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2
MEDICURE INTERN
SODIUM NITROPRUSSIDE (nitroprusside sodium)
NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2
DR.REDDY'S LAB
SODIUM NITROPRUSSIDE (nitroprusside sodium)
NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2
SLATE RUN PHARM
SODIUM NITROPRUSSIDE-0.9% NACL (nitroprusside sodium in 0.9 % sodium chloride)
NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2
SLATE RUN PHARM
SODIUM NITROPRUSSIDE (nitroprusside sodium)
NITROPRUSSIDE SODIUM · HYPERTENSIVE CRISIS ·+2
MEITHEAL PHARMA
Filter & compare in the drug finder →
Opens the drug finder with Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway preselected. Add indication or manufacturer filters there.
The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism.
Medications within this descriptive category, such as intravenous sodium nitroprusside and nitroglycerin, deliver or release exogenous nitric oxide to stimulate soluble guanylate cyclase in vascular smooth muscle.
This activation increases intracellular cyclic guanosine monophosphate (cGMP), triggering calcium reduction, vascular relaxation, and rapid vasodilation of arterial and venous beds.
Clinically, these parenteral agents are utilized for acute blood pressure control in acute hypertensive crises, perioperative hypotension induction, and acute decompensated heart failure.
-
fda.gov
The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism
-
fda.gov
The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism Medications within this descriptive category, such as intravenous sodium nitroprusside and nitroglycerin, deliver or release exogenous nitric oxide to stimulate soluble guanylate cyclase in vascular smooth muscle Th...
-
nih.gov
The phrase "Injectable Antihypertensive Agents,Nitric Oxide/cGMP pathway" is not a formal standalone regulatory drug class established by the FDA, but rather a functional classification combining parenteral blood-pressure-lowering medications with their underlying molecular mechanism Medications within this descriptive category, such as intravenous sodium nitroprusside and nitroglycerin, deliver or release exogenous nitric oxide to stimulate soluble guanylate cyclase in vascular smooth muscle Th...
-
inrae.fr
Medications within this descriptive category, such as intravenous sodium nitroprusside and nitroglycerin, deliver or release exogenous nitric oxide to stimulate soluble guanylate cyclase in vascular smooth muscle
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.